Similar articles for PMID: 23237992

Year	Number of Results
1998	1
2002	2
2003	2
2004	1
2005	3
2006	4
2007	2
2008	5
2009	3
2010	10
2011	9
2012	12
2013	11
2014	8
2015	16
2016	6
2017	2
2018	8
2019	3
2020	2
2021	2
2022	3
2023	2
2024	0

1

SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication.

Shao RX, Zhang L, Hong Z, Goto K, Cheng D, Chen WC, Jilg N, Kumthip K, Fusco DN, Peng LF, Chung RT. Shao RX, et al. Antiviral Res. 2013 Feb;97(2):101-7. doi: 10.1016/j.antiviral.2012.12.001. Epub 2012 Dec 10. Antiviral Res. 2013. PMID: 23237992 Free PMC article.

2

Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.

Liu B, Chen S, Guan Y, Chen L. Liu B, et al. PLoS One. 2015 Jul 20;10(7):e0133800. doi: 10.1371/journal.pone.0133800. eCollection 2015. PLoS One. 2015. PMID: 26193702 Free PMC article.

3

Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.

Shao RX, Zhang L, Peng LF, Sun E, Chung WJ, Jang JY, Tsai WL, Hyppolite G, Chung RT. Shao RX, et al. J Virol. 2010 Jun;84(12):6060-9. doi: 10.1128/JVI.02484-09. Epub 2010 Apr 7. J Virol. 2010. PMID: 20375166 Free PMC article.

4

MiR-221 accentuates IFN׳s anti-HCV effect by downregulating SOCS1 and SOCS3.

Xu G, Yang F, Ding CL, Wang J, Zhao P, Wang W, Ren H. Xu G, et al. Virology. 2014 Aug;462-463:343-50. doi: 10.1016/j.virol.2014.06.024. Epub 2014 Jul 12. Virology. 2014. PMID: 25019494 Free article.

5

Expression of SOCS1 and SOCS3 Genes in Interferon-Treated and Direct-Acting Antiviral Drugs-Treated Hepatitis C Patients.

Naz Z, Wahid B, Usman S, Saleem K, Rafique S, Ali A, Idrees M. Naz Z, et al. J Interferon Cytokine Res. 2018 Jun;38(6):255-260. doi: 10.1089/jir.2017.0138. J Interferon Cytokine Res. 2018. PMID: 29920131

6

The Coronavirus Transmissible Gastroenteritis Virus Evades the Type I Interferon Response through IRE1α-Mediated Manipulation of the MicroRNA miR-30a-5p/SOCS1/3 Axis.

Ma Y, Wang C, Xue M, Fu F, Zhang X, Li L, Yin L, Xu W, Feng L, Liu P. Ma Y, et al. J Virol. 2018 Oct 29;92(22):e00728-18. doi: 10.1128/JVI.00728-18. Print 2018 Nov 15. J Virol. 2018. PMID: 30185587 Free PMC article.

7

Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes.

Ye L, Wang S, Wang X, Zhou Y, Li J, Persidsky Y, Ho W. Ye L, et al. Drug Alcohol Depend. 2010 Nov 1;112(1-2):107-16. doi: 10.1016/j.drugalcdep.2010.05.008. Epub 2010 Jun 20. Drug Alcohol Depend. 2010. PMID: 20646875 Free PMC article.

8

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V. Grünvogel O, et al. J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12. J Virol. 2015. PMID: 26269178 Free PMC article.

9

Interferon alpha antagonizes STAT3 and SOCS3 signaling triggered by hepatitis C virus.

Zhao LJ, He SF, Wang W, Ren H, Qi ZT. Zhao LJ, et al. Cytokine. 2016 Apr;80:48-55. doi: 10.1016/j.cyto.2015.08.264. Epub 2016 Mar 3. Cytokine. 2016. PMID: 26945996

10

Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.

Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, Zeuge U, Windisch MP, Trippler M, Lohmann V, Binder M, Frese M, Bartenschlager R. Metz P, et al. Hepatology. 2012 Dec;56(6):2082-93. doi: 10.1002/hep.25908. Epub 2012 Oct 14. Hepatology. 2012. PMID: 22711689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year